i agree... even if cost savings were extraordinary, any current trial will not abandon and any drug that is approaching FDA approval will keep every protocol to not risk having the FDA restart their evaluation.
These delays are just asking for competition. this has taken so long that it would not shock me if Fedex or UPS comes out with their own solution and squashes us. that or we get picked up by one of them for the technology at a modest premium.. ie long term shareholders who have not averaged down would get F'ed in the you know where
News 
Market Data 
Discover 
